Press Releases Detail

Global Precision Medicine Market

avatar/IMG-10 by Foreclaro Global Research
2025 Jul, 31

According to the Foreclaro Global Research, the Global Precision Medicine Market size was valued at USD 86679.3 million in 2024. The report “Global Precision Medicine Market Segmentation By Technology (Bioinformatics, Big Data Analytics, Drug Discovery, Gene Sequencing, Companion Diagnostics, Others), By Application (Diagnostics {Genetic tests, Biomarker-based tests, Esoteric tests, Other tests}, Therapeutics {Inhibitor drugs, Monoclonal antibodies, Cell & gene therapy, Antiviral & anti-retroviral drugs, Other therapeutics}), By Sequencing Technology (Sequencing by Synthesis, Ion Semiconductor Sequencing, Sequencing by Ligation, Pyrosequencing, Single Molecule Real Time Sequencing, Chain Termination Sequencing, Nanopore Sequencing), By Route of Administration (Oral, Injectable)- Industry Trends and Forecast to 2033” gives a detailed insight into current market dynamics and provides analysis on future market growth.

 

Precision medicine is a transformative method to healthcare that tailors scientific remedies to the man or woman traits of every patient. By leveraging genetic, environmental, and lifestyle factors, precision medicine permits healthcare providers to are expecting extra appropriately which prevention and treatment techniques will paintings for unique groups of people. This technique is more and more in oncology, cardiovascular diseases, neurology, and uncommon genetic disorders, supporting in early diagnosis, centered therapy, and customized medicine plans. Technological improvements, which include next-generation sequencing, bioinformatics, and massive statistical analytics, have elevated the adoption of precision medicine. Moreover, the combination of synthetic intelligence and systems gaining knowledge of is allowing deeper insights into patient statistics, thereby enhancing decision-making in scientific settings. As the healthcare enterprise shifts from a one-size-fits-all version to individualized care, precision medicine plays a crucial role in enhancing treatment outcomes, minimizing side effects, and decreasing healthcare costs. Its speedy evolution is redefining the destiny of hospital treatment globally.

 

Have any questions or need more information? Click the link below to request a sample or make an inquiry before making your purchase:

https://foreclaroglobalresearch.com/research-report/global-precision-medicine-market

 

Global Precision Medicine Market Report Highlights

·       The precision treatment market is witnessing strong growth driven with the resource of the usage of developing personalized therapies, particularly in oncology, unusual diseases, and chronic conditions

·       Innovations in gene sequencing, bioinformatics, and AI-powered records analytics are permitting more correct diagnostics and centered medicine development.

·       Significant investment from governments, pharmaceutical companies, and studies establishments is boosting R&D efforts and strategic collaborations withinside the precision medicine ecosystem.

·       While most cancers stay the maximum critical segment, packages in neurology, cardiology, infectious diseases, and immunology are developing rapidly.

·       Regulatory our bodies are adapting to keep pace with advances in genomics and statistics usage, emphasizing affected character privacy, ethical AI use, and compliance.

·       North America leads the market due to strong healthcare infrastructure and innovation, while Asia-Pacific is growing as a fast-growing region with developing genomic initiatives.

 

Foreclaro Global Research has segmented the Precision Medicine Market report based on Technology, Application, Sequencing Technology, and region:

 

Precision Medicine Market, Technology Outlook (Revenue - USD Million, 2020 - 2033)

Bioinformatics

Big Data Analytics

Drug Discovery

Gene Sequencing

Companion Diagnostics

Others

 

Precision Medicine Market, Application Outlook (Revenue - USD Million, 2020 - 2033)

Diagnostics

·         Genetic tests

·         Biomarker-based tests

·         Esoteric tests

·         Other tests

Therapeutics

·         Inhibitor drugs

·         Monoclonal antibodies

·         Cell & gene therapy

·         Antiviral & anti-retroviral drugs

·         Other therapeutics

 

Precision Medicine Market, Sequencing Technology Outlook (Revenue - USD Million, 2020 - 2033)

Sequencing by Synthesis

Ion Semiconductor Sequencing

Sequencing by Ligation

Pyrosequencing

Single Molecule Real Time Sequencing

Chain Termination Sequencing

Nanopore Sequencing

 

Precision Medicine Market, Route of Administration Outlook (Revenue - USD Million, 2020 - 2033)

Oral

Injectable

 

Precision Medicine Market, Regional Outlook (Revenue - USD Million, 2020 - 2033)

North America

·         United States

·         Canada

·         Mexico

 

Europe

·         United Kingdom

·         Germany

·         France

·         Spain

·         Italy

·         Rest of Europe

 

Asia Pacific

·         China

·         India

·         Japan

·         Australia

·         South Korea

·         Rest of Asia Pacific

 

Latin America

·         Brazil

·         Argentina

·         Rest of Latin America

 

Middle East & Africa

·         Saudi Arabia

·         South Africa

·         Rest of MEA

 

Global Precision Medicine Market Key Players

·         Abbott Laboratories, Inc.

·         Abbvie, Inc.

·         AstraZeneca plc

·         bioMerieux SA

·         Bristol-Myers Squibb Company

·         Cepheid (Danaher Corporation)

·         Eli Lilly & Company

·         F. Hoffmann-La Roche

·         GlaxoSmithKline plc

·         Novartis AG